89Zr-pertuzumab
N/A
Report date: 2025/10/20 14:27:13
Base Information
Drug Name89Zr-pertuzumab
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenentech IncMemorial Sloan Kettering Cancer Center
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesMemorial Sloan Kettering Cancer CenterGenentech Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A